Display options
Share it on

Reumatologia. 2015;53(6):321-7. doi: 10.5114/reum.2015.57638. Epub 2016 Feb 11.

The relationship between the presence of autoantibodies, indicators of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with primary Sjögren's syndrome - a preliminary study.

Reumatologia

Maria Maślińska, Ewa Kontny, Brygida Kwiatkowska

Affiliations

  1. Early Arthritis Clinic, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.
  2. Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.

PMID: 27407265 PMCID: PMC4847284 DOI: 10.5114/reum.2015.57638

Abstract

OBJECTIVES: The aim of this study was to find markers related to activation of B cells, which show a correlation with the systemic inflammation markers - erythrocyte sedimentation rate and C-reactive protein and with the intensity of in situ inflammation.

MATERIAL AND METHODS: Forty-one primary Sjögren's syndrome (pSS) patients (33 female, 8 male) of the mean age 52.9 ±15 years were included. A group of 20 healthy volunteers was applied as a control. Erythrocyte sedimentation rate (ESR), concentration of gamma-globulins, C-reactive protein (CRP) and rheumatoid factor (RF) were measured by routine laboratory tests. Titres of antinuclear antibodies (ANAs) were determined by the indirect immunofluorescence method, while anti-SS-A/SS-B antibodies were detected by both the dot-blot method and an enzyme immunoassay. The concentrations of BAFF in sera were measured by sandwich ELISA. Biopsies of minor salivary glands were taken and the focus score (FS) was calculated. Correlations between quantitative variables were assessed using the Spearman correlation coefficient (r).

RESULTS: Serum concentrations of BAFF was significantly higher in the pSS patients than in the control group. The study revealed a statistically significant correlation between ANAs titre and the FS (r = 0.421). Anti-SS-A/Ro and anti-SS-B/La antibodies positively correlated with ESR. There was also a positive correlation between the gamma globulin level and the titres of all tested autoantibodies.

CONCLUSIONS: The positive correlation between ANAs and FS confirms the importance of these autoantibodies in the local inflammatory process. The positive correlation between anti-SS-A/SS-B antibodies and ESR suggests involvement of these antibodies in generalization of the inflammatory response. In the pSS group serum concentrations of BAFF were statistically significantly higher than healthy volunteers. All presented results confirm the role of activity of B cells in the course of pSS.

Keywords: B-cell activating factor; Sjögren's syndrome; autoantibodies

References

  1. Scand J Immunol. 2012 Jan;75(1):61-8 - PubMed
  2. Arthritis Rheum. 2009 Dec;60(12):3755-60 - PubMed
  3. Clin Exp Rheumatol. 2014 Jan-Feb;32(1):61-5 - PubMed
  4. Arthritis Res Ther. 2006;8(2):R51 - PubMed
  5. J Clin Invest. 2002 Jan;109(1):59-68 - PubMed
  6. Ann Rheum Dis. 2014 Jan;73(1):31-8 - PubMed
  7. Results Immunol. 2013 Nov 09;5:13-22 - PubMed
  8. Arthritis Res Ther. 2011 Feb 28;13(1):205 - PubMed
  9. Autoimmun Rev. 2012 Feb;11(4):252-8 - PubMed
  10. Am J Ophthalmol. 2010 Mar;149(3):405-15 - PubMed
  11. Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87 - PubMed
  12. Am J Ophthalmol. 2015 Dec;160(6):1150-1153.e3 - PubMed
  13. Arthritis Rheumatol. 2015 Sep;67(9):2427-36 - PubMed
  14. Neuroimmunomodulation. 2008;15(1):37-45 - PubMed
  15. Clin Dev Immunol. 2013;2013:160491 - PubMed
  16. Rheum Dis Clin North Am. 2000 Nov;26(4):927-49 - PubMed
  17. Presse Med. 2012 Sep;41(9 Pt 2):e475-83 - PubMed
  18. Ann Rheum Dis. 2003 Feb;62(2):168-71 - PubMed
  19. Rheumatology (Oxford). 2006 Feb;45(2):187-91 - PubMed
  20. Rheumatol Int. 2015 Feb;35(2):233-41 - PubMed
  21. Oral Health Prev Dent. 2013;11(3):229-34 - PubMed
  22. Curr Opin Rheumatol. 2013 Jul;25(4):480-7 - PubMed
  23. Arthritis Rheum. 2007 Apr;56(4):1134-44 - PubMed
  24. BMC Med. 2013 Apr 04;11:93 - PubMed
  25. Aust Prescr. 2015 Jun;38(3):93-4 - PubMed
  26. World J Gastroenterol. 2014 Sep 28;20(36):12839-46 - PubMed
  27. Clin Dev Immunol. 2012;2012:606195 - PubMed
  28. Clin Epidemiol. 2014 Jul 30;6:247-55 - PubMed
  29. Autoimmun Rev. 2013 Mar;12(5):558-66 - PubMed

Publication Types